U.S. markets open in 3 hours 6 minutes
  • S&P Futures

    3,676.75
    +12.25 (+0.33%)
     
  • Dow Futures

    30,055.00
    +123.00 (+0.41%)
     
  • Nasdaq Futures

    12,508.75
    +46.50 (+0.37%)
     
  • Russell 2000 Futures

    1,856.30
    +9.10 (+0.49%)
     
  • Crude Oil

    46.28
    +0.64 (+1.40%)
     
  • Gold

    1,842.90
    +1.80 (+0.10%)
     
  • Silver

    24.33
    +0.19 (+0.80%)
     
  • EUR/USD

    1.2171
    +0.0022 (+0.18%)
     
  • 10-Yr Bond

    0.9200
    0.0000 (0.00%)
     
  • Vix

    21.05
    -0.12 (-0.57%)
     
  • GBP/USD

    1.3454
    +0.0001 (+0.01%)
     
  • USD/JPY

    104.0150
    +0.1550 (+0.15%)
     
  • BTC-USD

    19,075.30
    -182.28 (-0.95%)
     
  • CMC Crypto 200

    374.63
    +0.22 (+0.06%)
     
  • FTSE 100

    6,548.79
    +58.52 (+0.90%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Corvus: 2Q Earnings Snapshot

BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported a loss of $11.6 million in its second quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 40 cents.

Corvus shares have fallen 9 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.42, a decline of 20 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS